Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 23:3:781353.
doi: 10.3389/frph.2021.781353. eCollection 2021.

Use of Moisturizers and Lubricants for Vulvovaginal Atrophy

Ayane Cristine Alves Sarmento  1 , Márcia Farina Kamilos  2 , Ana Paula Ferreira Costa  1 , Pedro Vieira-Baptista  3   4 , José Eleutério Jr  5 , Ana Katherine Gonçalves  1   6
Affiliations
Review

Use of Moisturizers and Lubricants for Vulvovaginal Atrophy

Ayane Cristine Alves Sarmento et al. Front Reprod Health. .

Abstract

The estrogen decrease in postmenopausal women results in functional and anatomical changes in the genitourinary tract. The most prevalent and bothersome symptoms are vaginal dryness, dyspareunia, and reduced lubrication, which can significantly affect the quality of life of these women, principally those who are sexually active. Hormonal therapy with local estrogens is generally considered the "gold standard." However, there are cases in which there are clinical concerns about its use or women opt for non-hormonal options. Thus, safe and effective non-hormonal options are needed to improve symptoms in these women. Moisturizers and lubricants are first-line therapy for breast cancer survivors.

Keywords: lubricants; menopause; moisturizers; non-hormonal treatment; vulvovaginal atrophy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the international society for the study of women's sexual health and the North American menopause society. Menopause. (2014) 21:1063–8. 10.1097/GME.0000000000000329 - DOI - PubMed
    1. Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, et al. . Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. (2016) 215:704–11. 10.1016/j.ajog.2016.07.045 - DOI - PubMed
    1. Cunha A, Machado R. Palmeira-de-Oliveira A, Martinez-de-Oliveira J, das Neves J, Palmeira-de-Oliveira R. Characterization of commercially available vaginal lubricants: a safety perspective. Pharmaceutics. (2014) 6:530–42. 10.3390/pharmaceutics6030530 - DOI - PMC - PubMed
    1. Perez-Lopez FR, Vieira-Baptista P, Phillips N, Sacher BC, Fialho SCAV, Stockdale CK. Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy. Gynecol Endocrinol. (2021) 37:740–5. 10.1080/09513590.2021.1931100 - DOI - PubMed
    1. Perez-Lopez FR, Phillips N, Vieira-Baptistac P, Cohen-Sacherf B, Fialhog SCAV, Stockdale CK. Management of postmenopausal vulvovaginal atrophy: recommendations of the international society for the study of vulvovaginal disease. Gynecol Endocrinol. (2021) 37:746–52. doilink[10.1080/09513590.2021.1943346]10.1080/09513590.2021.1943346 - PubMed

LinkOut - more resources